Navin Fluorine International Limited · NSE:NAVINFLUOR
Navin Fluorine International — Q1 FY18 Earnings Presentation
21 slides from Navin Fluorine International's earnings presentation, July 2017
Slide 1: Navin Fluorine International Limited Result Update Presentation Q1 FY18
Navin Fluorine International Limited Result Update Presentation Q1 FY18
Slide 2: Safe Harbor
Safe Harbor This presentation and the accompanying slides (the “Presentation”), which have been prepared by Navin Fluorine International Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe
Slide 3: Standalone Financial Highlights
Standalone Financial Highlights Revenue (Rs. Crs) EBITDA (Rs. Crs) +37% +47% 238 59 174 40 Q1 FY17^ Q1 FY18^ Q1 FY17^ Q1 FY18^ Operating PBT (Rs. Crs) Margins (%) +43% EBITDA Margin Operating PBT Margin 49 25.0% 34 23.1% 19.7% 20.5% Q1 FY17^ Q1 FY18^ Q1 FY17^ Q1 FY18^ ^ as per Ind AS financials 3
Slide 4: Quarter 1 Standalone Profitability Statement
Quarter 1 Standalone Profitability Statement [as per Ind AS] Particulars (Rs. Crs.) Q1 FY18 Q1 FY17 Change % Revenue from Operations 238 174 36% Raw Material 94 65 Excise Duty 13 12 Employee Expenses 21 18 Other Expenses 51 40 EBITDA 59 40 47% EBITDA Margin 25.0% 23.1% 185 bps Interest Expenses 0 0
Slide 5: Business Units Performance: Refrigerants and Inorganic Fluorides
Business Units Performance Refrigerants Inorganic Fluorides Revenue (Rs. Crs) +11% +8% 77 30 70 28 Q1 FY17^ Q1 FY18^ Q1 FY17^ Q1 FY18^ Exports Geographic Mix – Q1 FY18 10% Exports 29% Domestic Domestic 90% 71% * Standalone Results 5 ^ as per Ind AS financials
Slide 6: Business Units Performance: Specialty Chemicals and CRAMS
Business Units Performance Specialty Chemicals CRAMS Revenue (Rs. Crs) +1% +272% 57 58 72 19 Q1 FY17^ Q1 FY18^ Q1 FY17^ Q1 FY18^ Domestic 0% Geographic Mix – Q1 FY18 Exports 44% Exports 100% Domestic 56% * Standalone Results 6 ^ as per Ind AS financials
Slide 7: Revenue Mix: Business Unit Wise
Revenue Mix : Business Unit Wise 11% 30% 33% 24% 16% 13% 40% 33% Q1 FY17^ Q1 FY18^ CRAMS Specialty Chemicals Inorganic Fluorides Refrigerant Gases * Standalone Results ^ as per Ind AS financials 7
Slide 8: Annual Financial Performance
Annual Financial Performance# Refrigerants Increasing demands for cooling Traction in Key product Inorganic Fluorides solutions & as feedstock for portfolios & Customer segments Pharmaceutical industry to drive 120 94 215 214 long term growth 31% 17% FY16 FY17 FY16 FY17 Revenue Break-up FY17 CRAMS*
Slide 9: Strategy Begins to Yield Results
Strategy Begins to Yield Results Return on Net Worth # (%) Return on Capital Employed # (%) 19% 20% 18% 14% 12% 10% 11% 11% 9% 9% FY13 FY14 FY15 FY16 FY17 FY13 FY14 FY15 FY16 FY17 * Standalone Results 9 # - Calculated based on I GAAP Financials
Slide 10: Consistent Dividend Performance
Consistent Dividend Performance Dividend as % of Face Value Robust Dividend Payout Interim Final Special 315% ✓ Continuous Dividend since last 10 years ✓ Special Dividend of Rs. 60.00 per share 210% in FY12 150% 150% 150% 160% 160% 140% ✓ Declared Interim Dividend of Rs. 11.00 per share and a Specia
Slide 11: Standalone Profitability Statement [as per I GAAP]
Standalone Profitability Statement [as per I GAAP] Particulars (Rs. Crs.) FY17 FY16 Change % Revenue 701 636 10% Raw Material 286 292 Employee Expenses 77 66 Other Expenses 189 162 Operating EBITDA 150 116 29% Operating EBITDA Margin 21.4% 18.2% 320 bps Interest Expenses 0 3 Depreciation 28 21 Opera
Slide 12: Standalone Balance Sheet [as per I GAAP]
Standalone Balance Sheet [as per I GAAP] Equity and Liabilities (Rs. Crs.) Mar’17 Mar’16 Assets (Rs. Crs.) Mar’17 Mar’16 Shareholder’s Fund 748 634 Non-current assets 690 542 Share capital 10 10 Fixed assets 428 282 Tangible Assets 411 267 Reserves & Surplus 738 624 Intangible Assets 0 1 Non-current
Slide 13: Consolidated Profitability Statement [as per I GAAP]
Consolidated Profitability Statement [as per I GAAP] Particulars (Rs. Crs.) FY17 FY16 Change % Revenue 748 680 10% Raw Material 303 311 Employee Expenses 92 81 Other Expenses 195 171 Operating EBITDA 158 117 35% Operating EBITDA Margin 21.1% 17.2% 390 bps Interest Expenses 2 4 Depreciation 30 22 Ope
Slide 14: Consolidated Balance Sheet [as per I GAAP]
Consolidated Balance Sheet [as per I GAAP] Equity and Liabilities (Rs. Crs.) Mar’17 Mar’16 Assets (Rs. Crs.) Mar’17 Mar’16 Shareholder’s Fund 765 645 Non-current assets 689 608 Share capital 10 10 Fixed assets 460 307 Reserves & Surplus 755 636 Tangible Assets 428 286 Intangible Assets 0 1 Minority
Slide 15: Business Overview
Responsible Care” Business Overview e PADMANABH Ni MAFATLAL GROUP
Slide 16: Overview
Overview Built “India’s only plant with high pressure fluorination capabilities with cGMP compliance” for Largest Integrated Specialty Fluorochemical CRAMS Business Company in India Manufacturing plants strategically Over 45 years of expertise in Handling Fluorine located closer to major ports Stron
Slide 17: Business Units (BU) – Standalone
Business Units (BU) – Standalone CRAMS 03 • Leveraging our proven skills in Fluorination Chemistry • CRAMS for custom chemical syntheses of fluorinated compounds for the pharmaceuticals, agro chemicals and speciality chemicals industries 02 Specialty Chemicals • Large Scale Manufacture of Specialty
Slide 18: Clients across the Globe
Lj Clients across the Globe Ne. . . CLARIANT= ico) Bayer syngenta (eS) Bayer CropScience we tee W Novartis . LUPIN [8] HETERO Y Dr.Reppy's LIFE. RESEARCH . HOPE | | N e PADMANABH MAFATLAL GROUP
Slide 19: Key Strengths
Key Strengths Fluorination Capabilities In-house R&D ✓ Pioneered Manufacturing of ✓ State-of-the-art R&D centre – Navin Refrigerant Gases in India Research Innovation Centre at Surat ✓ Over 45 years of experience in ✓ DSIR approved R&D Centre handling Fluorine ✓ Supports in product addition & ✓ Exte
Slide 20: Growth driven by Every Business Unit
Growth driven by Every Business Unit CRAMS ✓ Business progression from Contract research to contract manufacturing ✓ Manufacturing facility commercially operational Specialty Chemicals ✓ Introduction of new high value added molecules in portfolio ✓ Entry into newer geographies Inorganic Fluorides ✓
Slide 21: Contact
Contact For further information, please contact: Company : Investor Relations Advisors : Navin Fluorine International Ltd. Strategic Growth Advisors Pvt. Ltd. CIN : L24110MH1998PLC115499 CIN : U74140MH2010PTC204285 Mr. Sitendu Nagchaudhuri Ms. Payal Dave / Mr Jigar Kavaiya Chief Financial Officer 98
Navin Fluorine International — Q1 FY18 Earnings Presentation on 6ix